{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-24-001539","form_type":"8-K","ticker":null,"cik":"0001708331","company_name":"Virpax Pharmaceuticals, Inc.","filed_at":"2024-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.297130+00:00","generated_at":"2026-05-30T21:36:28.597691+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Virpax appoints board member Katharyn Field as Vice President and principal executive officer","bullets":["Katharyn Field appointed VP and principal executive officer effective Sept. 27, 2024.","Field will continue to serve as a member of the Board of Directors.","Company is an emerging growth company; no prior CEO departure noted."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-24-001539","json":"https://secwatch.observer/filing/0001731122-24-001539.json","markdown":"https://secwatch.observer/filing/0001731122-24-001539.md","text":"https://secwatch.observer/filing/0001731122-24-001539.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708331/000173112224001539/0001731122-24-001539-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708331/000173112224001539/e6005_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T21:36:28.597691+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cce4d531a8","claim":"Katharyn Field was appointed as Vice President (principal executive officer) at Virpax Pharmaceuticals, Inc..","evidence_excerpt":"On September 27, 2024, the Board of Directors (the “Board”) of Virpax Pharmaceuticals, Inc. (the “Company”) appointed Katharyn Field, a member of the Board, to also serve as a Vice President (principal executive officer) of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708331/000173112224001539/0001731122-24-001539-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Vice President (principal executive officer)"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}